Ninth International Congress of Neuroimmunology

第九届国际神经免疫学大会

基本信息

  • 批准号:
    7614128
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-30 至 2009-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application requests partial support for the 9th International Congress of the International Society of Neuroimmunology sponsored by the International Society of Neuroimmunology (ISNI), which will take place in Fort Worth, Texas, from October 26 - 30, 2008. This will be the first Congress held in the United States since the 2nd International Congress held in Philadelphia in 1987. The congress will be preceded by a pre-congress program sponsored by the European School of Neuroimmunology, represented by leaders in the field of neuroimmunology. Drs. Michael K. Racke and Caroline C. Whitacre, are the Congress co-organizers. Dr. Whitacre is currently the Society's Vice-President and will become the President of ISNI at this meeting. She is a member of the International Advisory Committee of the Congress. The funds requested will be used by the congress organizers to encourage the attendance of junior and minority investigators in the field of Neuroimmunology. This congress is the major event in the international neuroimmunology calendar and is held every 2 or 3 years. Anticipated attendance is 1,200-1,500. Our 2004 ISNI Congress in Venice hosted 1200+ attendees and Nagoya in 2006, 1000+ attendees. Due to the increasing recognition of the key role of the immune system in many neurological diseases, neuroimmunology has become an important and continuously expanding biomedical field, encompassing a wide variety of disciplines ranging from genetics, basic immunology and neurobiology, through neurochemistry, pharmacology, endocrinology, neuropathology and neuroimmunomodulation, to clinical immunology and neurology. The scientific program will focus on basic mechanisms of immune surveillance, including new techniques in neuroimaging, repair of the nervous system, nervous system regulation of immune responses, and immunologic mechanisms of neurologic diseases. A heavy emphasis on new therapeutic approaches (gene, cell and immune-based therapies) in neurologic diseases (multiple sclerosis, gliomas, paraneoplastic syndromes, neuromuscular disorders, psychiatric disease, HIV encephalitis, viral infections, etc.), will permeate the program. Stem cell research in neural repair and mechanisms of neurodegeneration will also feature prominently. This request is for travel funds and will be used to encourage young and minority investigators (pre- and postdoctoral) to attend from around the world, in particular from less developed countries. The selection of candidates will be carried out by a local organizing committee in the United States. Because of the heavy emphasis on translational research, Continuing Medical Education credits will be offered at the congress and support will be requested to cover the costs associated with the administration of disclosure information and the overall accreditation process, which will ensure all congress presentations are balanced and free of bias for the participants. PUBLIC HEALTH RELEVANCE: Neuroimmunology is of great relevance to most degenerative neurologic conditions because the nervous system is in constant communication with the immune system and responds to almost any type of stress. The nervous system produces molecules that interact with the immune system and vice-versa, leading to important interactions when inflammation occurs in the nervous system. Neuroimmunology has tremendous relevance to public health in that immune responses can be either blocked or modulated thus making them amenable to therapy. The enormous strides made in multiple sclerosis and Alzheimer's disease in recent years have evolved from the application of therapeutic strategies that grew out of neuroimmunologic investigations.
描述(由申请人提供):本申请要求部分支持由国际神经免疫学学会(ISNI)主办的第九届国际神经免疫学学会国际大会,该大会将于2008年10月26日至30日在德克萨斯州沃斯堡举行。这将是自1987年在费城举行的第二届国际大会以来,首次在美国举行的大会。大会之前将有一个由欧洲神经免疫学学院主办的会前计划,由神经免疫学领域的领导者代表。Drs。Michael K. Racke和Caroline C. Whitacre是这次大会的共同组织者。Whitacre博士目前是协会副主席,并将在本次会议上成为ISNI主席。她是大会国际咨询委员会的成员。所申请的资金将由大会组织者用于鼓励神经免疫学领域的初级和少数研究人员参加会议。该大会是国际神经免疫学日历上的重大事件,每2年或3年举行一次。预计出席人数为1200 - 1500人。2004年在威尼斯举办的ISNI大会接待了1200多名与会者,2006年在名古屋举办的ISNI大会接待了1000多名与会者。由于人们越来越认识到免疫系统在许多神经系统疾病中的关键作用,神经免疫学已成为一个重要的、不断扩大的生物医学领域,涵盖了从遗传学、基础免疫学和神经生物学,到神经化学、药理学、内分泌学、神经病理学和神经免疫调节,再到临床免疫学和神经病学的广泛学科。该科学项目将侧重于免疫监测的基本机制,包括神经成像、神经系统修复、神经系统免疫反应调节和神经系统疾病的免疫机制方面的新技术。神经系统疾病(多发性硬化症、胶质瘤、副肿瘤综合征、神经肌肉疾病、精神疾病、艾滋病毒脑炎、病毒感染等)的新治疗方法(基因、细胞和免疫疗法)将渗透到该计划中。干细胞在神经修复和神经退行性变机制方面的研究也将成为重点。这项申请是旅费,将用于鼓励来自世界各地,特别是欠发达国家的年轻和少数民族研究人员(在读和博士后)参加会议。候选人的选拔将由美国当地的组委会进行。由于对转化研究的高度重视,大会将提供继续医学教育学分,并要求提供支持,以支付与信息披露管理和整个认证程序相关的费用,这将确保所有大会发言都是平衡的,对与会者没有偏见。公共卫生相关性:神经免疫学与大多数退行性神经系统疾病有很大的相关性,因为神经系统与免疫系统保持着持续的沟通,并对几乎任何类型的压力做出反应。神经系统产生与免疫系统相互作用的分子,反之亦然,当神经系统发生炎症时,导致重要的相互作用。神经免疫学与公共卫生有着巨大的相关性,因为免疫反应可以被阻断或调节,从而使它们适合治疗。近年来,在多发性硬化症和阿尔茨海默病方面取得的巨大进展,是从神经免疫学研究中产生的治疗策略的应用中发展而来的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL K RACKE其他文献

MICHAEL K RACKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL K RACKE', 18)}}的其他基金

CLINICAL TRIAL: BETASERON/BETAFERON IN MS
临床试验:BETASERON/BETAFERON 在 MS 中的应用
  • 批准号:
    7718677
  • 财政年份:
    2007
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    6748111
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    7497835
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    6614757
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    6884627
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    7238737
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
Immunopathogenesis of Multiple Sclerosis
多发性硬化症的免疫发病机制
  • 批准号:
    7052790
  • 财政年份:
    2003
  • 资助金额:
    $ 2.5万
  • 项目类别:
MECHANISM OF COPAXONE THERAPY IN MS
科帕松治疗多发性硬化症的机制
  • 批准号:
    6085879
  • 财政年份:
    1999
  • 资助金额:
    $ 2.5万
  • 项目类别:
MECHANISM OF COPAXONE THERAPY IN MS
科帕松治疗多发性硬化症的机制
  • 批准号:
    6170766
  • 财政年份:
    1999
  • 资助金额:
    $ 2.5万
  • 项目类别:
MECHANISM OF COPAXONE THERAPY IN MS
科帕松治疗多发性硬化症的机制
  • 批准号:
    6374448
  • 财政年份:
    1999
  • 资助金额:
    $ 2.5万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 2.5万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 2.5万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 2.5万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 2.5万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 2.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了